Long-term global quality of life in patients treated for colorectal liver metastases

British Journal of Surgery

Volumn 98, Issue 4, 2011, Pages 565-571

  Wiering, B ^a   Oyen, W J G ^a   Adang, E M M ^a   Van Der Sijp, J R M ^b   Roumen, R M ^d   De Jong, K P ^e   Ruers, T J M ^c   Krabbe, P F M ^e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS;

EID: 79951977946     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7365     Document Type: Article

References (30)

1. Parkin DM,. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543. (Pubitemid 33586866)
2. Greenway B,. Hepatic metastases from colorectal cancer: resection or not. Br J Surg 1988; 75: 513-519.
3. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM,. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240: 438-447.
4. Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, et al., Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 2007; 14: 1161-1169.
5. Byrne C, Griffin A, Blazeby J, Conroy T, Efficace F,. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer. Eur J Surg Oncol 2007; 33 (Suppl 2): S95-S104. (Pubitemid 350216637)
6. Gall CA, Weller D, Esterman A, Pilotto L, McGorm K, Hammett Z, et al., Patient satisfaction and health-related quality of life after treatment for colon cancer. Dis Colon Rectum 2007; 50: 801-809. (Pubitemid 46870439)
7. Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ,. Quality of life as an outcome measure in surgical oncology. Br J Surg 2001; 88: 643-652. (Pubitemid 34014630)
8. Mohler MJ, Coons SJ, Hornbrook MC, Herrinton LJ, Wendel CS, Grant M, et al., The health-related quality of life in long-term colorectal cancer survivors study: objectives, methods and patient sample. Curr Med Res Opin 2008; 24: 2059-2070.
9. Pucciarelli S, Del Bianco P, Toppan P, Serpentini S, Efficace F, Pasetto LM, et al., Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 1846-1854.
10. Sharma A, Sharp DM, Walker LG, Monson JR,. Predictors of early postoperative quality of life after elective resection for colorectal cancer. Ann Surg Oncol 2007; 14: 3435-3442. (Pubitemid 350160122)
11. Wilson TR, Alexander DJ,. Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. Br J Surg 2008; 95: 1408-1415.
12. Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ,. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg 2006; 93: 1007-1014. (Pubitemid 44214853)
13. Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, et al., Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 2009; 50: 1036-1041.
14. Kind P, Lafata JE, Matuszewski K, Raisch D,. The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health 2009; 12 (Suppl 1): S27-S30.
15. Fanshel S, Bush JW,. A health-status index and its application to health-services outcomes. Oper Res 1970; 18: 1021-1066.
16. Torrance GW, Feeny D,. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989; 5: 559-575. (Pubitemid 20153102)
17. Gelber RD, Goldhirsch A,. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 1986; 4: 1772-1779. (Pubitemid 17226666)
18. Revicki DA, Feeny D, Hunt TL, Cole BF,. Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data. Qual Life Res 2006; 15: 411-423.
19. Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK,. An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 1997; 35: 522-537. (Pubitemid 127455049)
20. Dolan P,. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108. (Pubitemid 127453463)
21. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al.,; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016. (Pubitemid 351392040)
22. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al., Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006; 24: 4976-4982. (Pubitemid 46631399)
23. Dasgupta D, Smith AB, Hamilton-Burke W, Prasad KR, Toogood GJ, Velikova G, et al., Quality of life after liver resection for hepatobiliary malignancies. Br J Surg 2008; 95: 845-854.
24. Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M,; European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Group. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg 2009; 96: 291-298.
25. Nunnally JC, Bernstein IH,. Psychometric Theory. McGraw-Hill: New York, 1994.
26. Stevens SS,. On the theory of scales of measurement. Science 1946; 103: 677-680.
27. Krabbe PF,. Thurstone scaling as a measurement method to quantify subjective health outcomes. Med Care 2008; 46: 357-365.
28. Feinstein AR,. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983; 99: 843-848. (Pubitemid 14248416)
29. Wright JG, Feinstein AR,. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol 1992; 45: 1201-1218.
30. Brazier J, Tsuchiya A,. Preference-based condition-specific measures of health: what happens to cross programme comparability? Health Econ 2010; 19: 125-129.